Literature DB >> 22766886

New lipid and lipoprotein targets for the treatment of cardiometabolic diseases.

Stanley L Hazen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22766886      PMCID： PMC3413215          DOI： 10.1194/jlr.E030205

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  15 in total

1.  The mechanism of the plasma cholesterol esterification reaction: plasma fatty acid transferase.

Authors:  J A GLOMSET
Journal:  Biochim Biophys Acta       Date:  1962-11-19

2.  Statin therapy for healthy men identified as "increased risk".

Authors:  Michael J Blaha; Khurram Nasir; Roger S Blumenthal
Journal:  JAMA       Date:  2012-04-11       Impact factor: 56.272

3.  Global cardiovascular risk associated with hypertension and extent of treatment and control according to risk group.

Authors:  Nathan D Wong; Jennifer Dede; Vincent H Chow; Ken S Wong; Stanley S Franklin
Journal:  Am J Hypertens       Date:  2012-02-09       Impact factor: 2.689

Review 4.  Evidence mandating earlier and more aggressive treatment of hypercholesterolemia.

Authors:  Daniel Steinberg; Christopher K Glass; Joseph L Witztum
Journal:  Circulation       Date:  2008-08-05       Impact factor: 29.690

5.  Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women.

Authors:  Stephanie E Chiuve; Teresa T Fung; Kathryn M Rexrode; Donna Spiegelman; JoAnn E Manson; Meir J Stampfer; Christine M Albert
Journal:  JAMA       Date:  2011-07-06       Impact factor: 56.272

6.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

Review 7.  PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty.

Authors:  Janice V Huang; Clifford R Greyson; Gregory G Schwartz
Journal:  J Lipid Res       Date:  2012-06-08       Impact factor: 5.922

8.  The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

Authors: 
Journal:  JAMA       Date:  1984-01-20       Impact factor: 56.272

9.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

10.  The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors.

Authors:  Goodarz Danaei; Eric L Ding; Dariush Mozaffarian; Ben Taylor; Jürgen Rehm; Christopher J L Murray; Majid Ezzati
Journal:  PLoS Med       Date:  2009-04-28       Impact factor: 11.069
View more
  2 in total

1.  Marine biogenics in sea spray aerosols interact with the mTOR signaling pathway.

Authors:  Jana Asselman; Emmanuel Van Acker; Maarten De Rijcke; Laurentijn Tilleman; Filip Van Nieuwerburgh; Jan Mees; Karel A C De Schamphelaere; Colin R Janssen
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

2.  Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research.

Authors:  Ning Yu; Ruirui Wang; Baocheng Liu; Lei Zhang
Journal:  Front Cardiovasc Med       Date:  2022-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.